Skip Navigation
Stash

Browse investments

Invest in Keros Therapeutics, Inc. on Stash

Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company.

To buy fractional shares

of Keros Therapeutics, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Keros Therapeutics, Inc.

Ticker: KROS

Keros Therapeutics, Inc.

$60.82

-4.69%

(1W)

$

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

KROS Performance Breakdown

Share Price

$60.82

Today's change

2.62%

Year to date change (YTD)

41.02%

Dividend yield

0.0

Last dividend paid

N/A

Last dividend pay date

N/A

About KROS

Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. Its protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes (MDS) and myelofibrosis. Its small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from elevated levels of hepcidin, the key regulator of iron absorption and recycling, as well as for the treatment of fibrodysplasia ossificans progressive. KER-047 is in a Phase I clinical trial. Its KER-012 is being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension.

Keros Therapeutics, Inc. Stock Ticker

KROS

For more information

https://www.kerostx.com

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

Certain companies are volatile.

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Keros Therapeutics, Inc. stock news

This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.

CNBC
U.S. oil falls below $83 as war fears ease after Israel refrains from immediate Iran counterattack

Oil has sold off 4% this week as traders unwind the geopolitical risk premium built into prices over the last two weeks.

about 3 hours ago

Business Insider
Boeing whistleblower claims there is a 'criminal coverup' over the 737 Max blowout

Boeing has said there's no documents of work done on the door plug that came off an Alaska Airlines 737 Max. Ed Pierson, a former Boeing manager, testified that another whistleblower gave him these documents.

about 2 hours ago

24/7 Wall Street
5 Blue Chip REITs Deliver Huge and Dependable Monthly Dividends

Essential Tips for Investing: Sponsored A financial advisor can help you understand the advantages and disadvantages of investment properties.

about 5 hours ago

See It Market
Two Consumer Stocks With Unusual Earnings Reporting Dates

The following research was contributed to by Christine Short, VP of Research at Wall Street Horizon. Q1 earnings season is in full swing.

1 day ago

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.†

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,8 recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.1

Learn how to invest

Get professional advice and education at every step.

How to buy Keros Therapeutics, Inc. stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Stash offers two subscription plans: Stash Growth and Stash+.

Once your market order of Keros Therapeutics, Inc. stock is complete, you'll officially be a shareholder of Keros Therapeutics, Inc.!

Invest in Keros Therapeutics, Inc. on Stash

Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company.

To buy fractional shares

of Keros Therapeutics, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Stash resources for confident investing

How to Start Investing: A Comprehensive Guide for Beginners

What Are Fractional Shares?

How To Read a Stock Chart: A Beginner’s Guide + Stock Chart Glossary

Subscribe to The Wallet!

Looking for financial guidance? Check your Wallet. Every week, your inbox will be packed with market savviness and clever money management techniques. Sign up today!

By using this website you agree to our Terms of Use and Privacy Policy.

More Health Care stocks
Astria Therapeutics, Inc.

Astria Therapeutics, Inc.

2.18%

Theravance Biopharma Inc

Theravance Biopharma Inc

-0.63%

Solventum Corp

Solventum Corp

1.94%

National HealthCare Corporation

National HealthCare Corporation

0.69%

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc.

0.35%

Hims & Hers Health, Inc.

Hims & Hers Health, Inc.

1.33%

Amedisys Inc

Amedisys Inc

0.23%

Seres Therapeutics Inc

Seres Therapeutics Inc

-2.18%

Aveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc

2.25%

Galapagos NV

Galapagos NV

-0.36%

View All

Ready to start
building wealth?

By using this website you agree to our Terms of Use and Privacy Policy.

Google PlayApp Store
InstagramTwitterLinkedIn5967A220-6EC0-46D6-8A99-1222576A842ACreated with sketchtool.FacebookYouTube

Legal  |  Privacy Policy

  • †Stash offers access to investment and banking accounts under each subscription plan. Each type of account is subject to different regulations and limitations. Subscription fee starts at $3/month. You’ll also bear standard fees and expenses reflected in the pricing of the ETFs, plus fees for various ancillary services charged by Stash and the Custodian. Please see Advisory Agreement for details. Other fees apply to the bank account. Please see Deposit Account Agreement for details.
  • § Depending on the subscription plan, there may be additional steps a user must take to cancel their account which may impact the amount of time it takes to fully close an account.

  • ‡ Group life insurance coverage provided through Avibra, Inc. Stash is a paid partner of Avibra. Only individuals ages 18-54 and who are residents of one of the 50 U.S. states or DC are eligible for group life insurance coverage, subject to availability. Individuals with certain pre-existing medical conditions may not be eligible for the full coverage above, but may instead receive less coverage. All insurance products are subject to state availability, issue limitations and contractual terms and conditions, any of which may change at any time and without notice. Please see Terms and Conditions for full details. Stash may receive compensation from business partners in connection with certain promotions in which Stash refers clients to such partners for the purchase of non-investment consumer products or services. Clients are, however, not required to purchase the products and services Stash promotes.

  1. Stash Banking services provided by Stride Bank, N.A., Member FDIC. The Stash Stock-Back® Debit Mastercard® is issued by Stride Bank pursuant to license from Mastercard International. Mastercard and the circles design are registered trademarks of Mastercard International Incorporated. Any earned stock rewards will be held in your Stash Invest account. Investment products and services provided by Stash Investments LLC, not Stride Bank, and are Not FDIC Insured, Not Bank Guaranteed, and May Lose Value. In order for a user to be eligible for a Stash banking account, they must also have opened a taxable brokerage account on Stash.

    All rewards earned through use of the Stash Stock-Back® Debit Mastercard® will be fulfilled by Stash Investments LLC. You will bear the standard fees and expenses reflected in the pricing of the investments that you earn, plus fees for various ancillary services charged by Stash. In order to earn stock in the program, the Stash Stock-Back® Debit Mastercard must be used to make a qualifying purchase. What doesn’t count: Cash withdrawals, money orders, prepaid cards, and P2P payment. If you make a qualifying purchase at a merchant that is not publicly traded or otherwise available on Stash, you will receive a stock reward in an ETF or other investment of your choice from a list of companies available on Stash. 1% Stock-Back® rewards are subject to terms and conditions. Stock rewards that are paid to participating customers via the Stash Stock Back program, are Not FDIC Insured, Not Bank Guaranteed, and May Lose Value. Stash reserves the right to amend this program and the terms and conditions thereof and/or cancel this program at any time, for any reason, upon notice to you. See Terms and Conditions for more details.

  2. Get fee-free transactions at any Allpoint ATM, see the app for location details, otherwise out-of-network ATM fees may apply. For a complete list of fees please see the Deposit Account Agreement for details.
  3. Early access to direct deposit funds depends on when the payor sends the payment file. We generally make these funds available on the day the payment file is received, which may be up to 2 days earlier than the scheduled payment date.
  4. Stash does not monitor whether a customer is eligible for a particular type of IRA, or a tax deduction, or if a reduced contribution limit applies to a customer. These are based on a customer’s individual circumstances. You should consult with a tax advisor.
  5. The money in a custodial account is the property of the minor.
  6. Not all stocks pay out dividends.
  7. This is a Discretionary Managed Account whereby Stash has full authority to manage. Diversification and asset allocation do not guarantee a profit, nor do they eliminate the risk of loss of principal. Stash does not guarantee any level of performance or that any client will avoid losses in the client’s account.
  8. A “Personal Portfolio” is a non-Discretionary Managed Account.
  9. Stash through the “Diversification Analysis” feature does not rebalance portfolios or otherwise manage the Personal Portfolio Account for clients on a discretionary basis. Recommendations through this tool are considered personalized investment advice. No asset allocation is a guarantee against loss of principal.
  10. To be eligible to receive a Stock Reward through stock party, you must complete the account registration process and open an individual taxable brokerage account ("Personal Portfolio") that is in good standing. This program is subject to Terms and Conditions.
  11. If you purchase this plan, you will receive Financial Counseling Advice which is impersonal investment advice, as guides, reports, and education material about investing and financial planning. Each plan includes the option to open a brokerage account and a bank account. The subscription fee is due if a client is receiving Financial Counseling Services regardless of whether or not a client chooses to open and/or use a brokerage account. In order to obtain personalized investment advice, clients are required to complete the suitability questionnaire during registration, must be approved from an account verification perspective and open a brokerage account. Click here for more details.
  12. You may subsequently choose to open one or more investment advisory account(s). To begin investing on Stash, you must be approved from an account verification perspective and open a brokerage account.
  13. This Program is subject to terms and conditions. In order to participate, a user must comply with all eligibility requirements and make a qualifying purchase with their Stock-Back® Card. All funds used for this Program will be taken from your Stash Banking account†.
  14. Unpaid client testimonials. Not representative of all clients and not a guarantee. See Apple App Store and Google Play reviews. Immaterial changes have been made to these quotes for editorial purposes.
  15. Based on comparative data on debit cards in the U.S that offer stock rewards when used to shop at publicly traded companies.
  • Nothing on this website should be considered an offer, solicitation of an offer, tax, legal, or investment advice to buy or sell securities. Any historical returns, expected returns or probability projections are hypothetical in nature and may not reflect actual future performance. Account holdings are for illustrative purposes only and are not investment recommendations. All investments are subject to risk and may lose value. If applicable, your Stash banking account is a funding account for purposes of the Advisory Agreement. Your subscription fee may be deducted from your Stash banking account balance.
  • By clicking on any third-party links above, you will leave Stash’s website and link to a non-affiliated third-party website. The privacy practices of those third parties may differ from those of Stash. Therefore, we recommend you review the privacy statements of those third-party websites, as Stash is not responsible for those third parties' privacy or security practices.
  • All individuals featured on this website are paid actors or employees of Stash.
  • By using this website, you understand the information being presented is provided for informational purposes only and agree to our Terms of Use and Privacy Policy. Stash does not provide comprehensive financial planning services to individual investors. Stash Financial, Inc. is a digital financial services company offering financial products for U.S. based consumers. Stash is not a bank or depository institution licensed in any jurisdiction Advisory products and services are offered through Stash Investments LLC (“Stash”), an SEC registered investment adviser. Stash Capital LLC, an SEC registered broker-dealer and member FINRA/SIPC, serves as introducing broker for Stash Clients’ advisory accounts. FINRA BrokerCheck reports for Apex Clearing are available at https://brokercheck.finra.org/. Apex Clearing Corporation, a third-party SEC registered broker-dealer and member FINRA/SIPC, provides clearing and execution services and serves as qualified custodian for advisory assets of Stash Clients. Products offered by Stash Investments LLC and Stash Capital LLC are Not FDIC Insured, Not Bank Guaranteed, and May Lose Value. Market data by Thomson Reuters (Refinitiv).
  • For more information, see our disclosures.
  • All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.
  • Stash supports an accessible internet. If you have any questions about our features, please contact us at accessibility@stash.com. Information provided by Stash Support is for informational and general educational purposes only and is not investment or financial advice.
  • Email: support@stash.com Tel: (800) 205-5164
    Google Play and the Google Play logo are trademarks of Google, Inc.
    Apple, the Apple logo, and iPhone are trademarks of Apple, Inc., registered in the U.S.
    STASH, StashInvest, and Stock-Back are registered trademarks of Stash Financial, Inc.
    © Copyright 2024 Stash Financial, Inc. All rights reserved.